ANGO
ANGIODYNAMICS INC
+0.01 (+0.06%)15.47USD203K成交股數639M市值–本益比(近四季)2.0股價營收比+8.9%營收年增(近四季)2026-10-01下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 5 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 86.6M+20% | 78.4M+8% | 79.4M+18% | 75.7M+7% | 72.0M-4% | 72.8M-8% | 67.5M-14% | 71.0M-12% | 75.2M | 79.1M | 78.7M | 80.7M |
| 營業成本 | 39.8M | 36.9M | 34.7M | 33.9M | 33.1M | 32.9M | 30.8M | 32.5M | 39.3M | 38.8M | 38.6M | 40.2M |
| 毛利 | 46.8M+20% | 41.5M+4% | 44.8M+22% | 41.9M+9% | 38.9M+8% | 39.9M-1% | 36.7M-8% | 38.5M-5% | 35.9M | 40.3M | 40.1M | 40.5M |
| 毛利率 | 54.0% | 52.9% | 56.4% | 55.3% | 54.0% | 54.8% | 54.4% | 54.3% | 47.7% | 50.9% | 50.9% | 50.2% |
| 研發費用 | 8.2M | 7.1M | 7.8M | 6.4M | 6.9M | 6.4M | 6.3M | 6.7M | 8.2M | 8.7M | 7.9M | 6.9M |
| 銷售管理費用 | 10.3M | 10.7M | 10.2M | 12.6M | 10.5M | 10.4M | 11.0M | 10.4M | 10.6M | 9.3M | 10.9M | 8.8M |
| 營業利益 | −10.2M+2% | −13.0M+17% | −6.1M-53% | −10.7M-26% | −10.0M-95% | −11.1M-15% | −13.1M-137% | −14.4M+62% | −200M | −13.1M | 35.0M | −8.9M |
| 營業利益率 | -11.8% | -16.5% | -7.7% | -14.1% | -13.9% | -15.2% | -19.4% | -20.4% | -265.9% | -16.6% | 44.5% | -11.1% |
| 稅後淨利 | −11.4M+159% | −8.1M-25% | −6.4M-50% | −10.9M-19% | −4.4M-98% | −10.7M-63% | −12.8M-128% | −13.4M+42% | −188M | −29.0M | 45.9M | −9.5M |
| 淨利率 | -13.2% | -10.3% | -8.0% | -14.4% | -6.1% | -14.7% | -19.0% | -18.9% | -249.7% | -36.7% | 58.3% | -11.8% |
| 稀釋 EPS | -0.28+155% | -0.19-27% | -0.15-52% | -0.26-26% | -0.11-98% | -0.26-64% | -0.31-127% | -0.35+46% | -4.67 | -0.72 | 1.15 | -0.24 |
| 稀釋股數 | 41.5M | 41.6M | 41.5M | 41.2M | 40.9M | 40.9M | 40.7M | 40.2M | 40.2M | 40.2M | 40.0M | 39.5M |
資產負債表 期末餘額
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 53.9M | 37.8M | 41.6M | 38.8M | 44.8M | 54.1M | 55.0M | 76.1M | 78.5M | 60.9M | 57.6M | 30.1M |
| 應收帳款 | 48.3M | 45.6M | 44.4M | 42.6M | 43.5M | 43.2M | 39.6M | 43.6M | 49.5M | 51.6M | 49.8M | 50.9M |
| 存貨 | 52.4M | 58.6M | 65.6M | 62.3M | 63.1M | 65.9M | 64.7M | 60.6M | 58.1M | 64.3M | 60.0M | 63.5M |
| 總資產 | 267M | 261M | 270M | 266M | 285M | 292M | 294M | 318M | 325M | 500M | 494M | 543M |
| 有息負債 | – | – | – | – | – | – | – | 0 | – | – | – | 49.8M |
| 總負債 | 96.3M | 87.3M | 93.3M | 86.8M | 99.5M | 105M | 97.0M | 112M | 106M | 98.4M | 66.1M | 145M |
| 股東權益 | 171M | 173M | 176M | 179M | 186M | 187M | 197M | 206M | 219M | 401M | 428M | 398M |
| 負債比 | 36.1% | 33.5% | 34.6% | 32.7% | 34.9% | 35.9% | 33.1% | 35.3% | 32.7% | 19.7% | 13.4% | 26.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | 76.1M | – | – | – | −19.7M |
現金流量表 單季
| 科目 | 26Q4 | 26Q3 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | −15.9M | – | – | −18.3M-30% | – | – | – | −25.9M | – |
| 資本支出 | – | – | – | 731K | – | – | 1.1M | – | – | – | 791K | – |
| 自由現金流 | – | – | – | −16.6M | – | – | −19.3M-28% | – | – | – | −26.7M | – |
| 折舊攤銷 | – | – | – | 6.0M | – | – | 6.8M | – | – | – | 6.7M | – |
| 買回庫藏股 | – | – | – | 0 | – | – | 552K | – | – | – | 0 | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | -22.0% | – | – | -28.7% | – | – | – | -33.9% | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 320M
| Med Device | 170M | 53.2% | +2.6% |
|---|---|---|---|
| Med Tech | 150M | 46.8% | +18.4% |
地區2026 年度 · 320M
| 美國 | 275M | 85.9% | +9.5% |
|---|---|---|---|
| 美國以外 | 45.3M | 14.1% | +9.0% |
產品／服務2026 年度 · 320M
| Med Device | 170M | 53.2% | +2.6% |
|---|---|---|---|
| Med Tech | 150M | 46.8% | +18.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 320M | +9.5% | −36.7M | -11.5% | -0.88 | 508K |
| FY2025 | 292M | -3.8% | −34.0M | -11.6% | -0.83 | −14.6M |
| FY2024 | 304M | -10.3% | −184M | -60.7% | -4.59 | −30.7M |
| FY2023 | 339M | +7.1% | −52.4M | -15.5% | -1.33 | −3.7M |
| FY2022 | 316M | +8.7% | −26.5M | -8.4% | -0.68 | −11.5M |
| FY2021 | 291M | +10.2% | −31.5M | -10.8% | -0.82 | 18.9M |
| FY2020 | 264M | -2.4% | −167M | -63.1% | -4.39 | −21.8M |
| FY2019 | 271M | – | 61.3M | 22.7% | 1.64 | 34.3M |